Expression profiling of favorable and unfavorable neuroblastomas

Pediatric Surgery International

Volumn 20, Issue 1, 2004, Pages 33-38

  Hiyama, Eiso ^a   Hiyama, Keiko ^b   Yamaoka, Hiroaki ^a   Sueda, Taijiro ^a   Reynolds, C Patrik ^c   Yokoyama, Takashi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Maturation; Microarray; Neuroblastoma; Outcome; Regression

Indexed keywords

APOPTOSIS; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER REGRESSION; CAUSE OF DEATH; CELL DIFFERENTIATION; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA LIBRARY; DNA MICROARRAY; DOWN REGULATION; GENE CLUSTER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; CLASSIFICATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; INFANT; TUMOR REGRESSION;

APOPTOSIS INDUCING FACTOR; C6ORF12 PROTEIN, HUMAN; CARBOCYANINE; CELL CYCLE PROTEIN; CYANINE DYE 3; CYANINE DYE 5; DIAGNOSTIC AGENT; FLAVOPROTEIN; FLUORESCENT DYE; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN; MYCN PROTEIN, HUMAN; NERVE PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; PDCD8 PROTEIN, HUMAN;

APOPTOSIS; APOPTOSIS INDUCING FACTOR; CARBOCYANINES; CAUSE OF DEATH; CELL CYCLE PROTEINS; DOWN-REGULATION; FLAVOPROTEINS; FLUORESCENT DYES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INFANT; MEMBRANE PROTEINS; NEOPLASM REGRESSION, SPONTANEOUS; NERVE TISSUE PROTEINS; NEUROBLASTOMA; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS; UP-REGULATION;

EID: 2942550474     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-003-1077-3     Document Type: Article

References (14)

1. Westermann F, Schwab M (2002) Genetic parameters of neuroblastomas. Cancer Lett 184:127-147
2. Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3:203-216
3. Schena M, Shalon D, Davis RW, et al (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467-470
4. Osin P, Shipley J, Lu YJ, et al (1998) Experimental pathology and breast cancer genetics: new technologies. Recent Results Cancer Res 152:35-48
5. Hiyama E, Hiyama K (2002) Clinical application of microarrays as a tool of understanding cancer biology. In: Pandalai SG (ed) Recent research developments in cancer. Transworld Research Network, Kerala, India 4, pp 675-692
6. Zhang K, Zhao H (2000) Assessing reliability of gene clusters from gene expression data. Funct Integr Genomics 1:156-173
7. Gluer S, Zense M, von Schweinitz D (1998) Cell adhesion molecules and intermediate filaments on embryonal childhood tumors. Pathol Res Pract 194:773-780
8. Gomez-Santos C, Ambrosio S, Ventura F, et al (2002) TGF-beta1 increases tyrosine hydroxylase expression by a mechanism blocked by BMP-2 in human neuroblastoma SH-SY5Y cells. Brain Res 958:152-160
9. Godfried MB, Veenstra M, Sluis P, et al (2002) The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Oncogene 21:2097-2101
10. Hiyama E, Hiyama K, Yokoyama T, et al (1995) Correlating telomerase activity levels with human neuroblastoma out-comes. Nature Med 1:249-255
11. Hiyama E, Hiyama K, Ohtsu K, et al (1997) Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behavior? Eur J Cancer 33:1932-1936
12. Hoehner JC, Hedborg F, Eriksson L, et al (1998) Developmental gene expression of sympathetic nervous system tumors reflects their histogenesis. Lab Invest 78:29-45
13. Kushner BH, Cheung NK, LaQuaglia MP, et al (1996) International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review. J Clin Oncol 14:2174-2180
14. Shimada H, Chatten J, Newton WJ, et al (1984) Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405-416